The sealed overcap protects misuse, safe for airline transport, labeling space
Inner cap, when pushed, actives the device: no needle stick risk
Next inner cap expands to protect the needle: no needle stick risk
Any User does not see the needle
Blow fill seal manufacturing: BFS
No silicone / biological molecule interactions, lacks suspended particulates
First class engineering support: Weiler-since 2010 and PADT since 2009
CAD drawings for both QI and QISS
A Single step process: PFS-pre-filled syringes: separate mfg.* and filling
We expect cost savings for most product run cycles
Syringes made to specific cc requirements
For high cost and hard to make biologicals we expect less product waste
Plastic materials: we anticipate multiple choice types to be available
Both devices use the BFS process to put the injectable liquid into a bellow. Our animation video, available upon request, clearly shows the unique aspects of both devices.
Our CEO James N. Stevenson has worked in the pharmaceutical industry for more than 30 years knows and how well this unique device and process will fit into the industry. He was involved in selecting PADT in 2009. In 2018 he gained control of the business.
Our goals:
To create one to one leasing agreements.
Contracts are private and between us and an interested party.
